Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mindray Medical International Ltd Raises FY 2013 Revenue Guidance; Reaffirms FY 2013 Net Income Guidance


Monday, 5 Aug 2013 05:00pm EDT 

Mindray Medical International Ltd announced that for fiscal 2013, it raising revenue guidance, expecting at least 18% growth over fiscal 2012 net revenues. The company maintains fiscal 2013 non-GAAP net income guidance, expecting at least 15% growth over its non-GAAP net income for the fiscal 2012. The Company reported revenue of $1.060 billion and net income of $180.2 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.238 billion and net income of $228.3 million for fiscal 2013. 

Company Quote

30.53
-0.21 -0.68%
29 Jul 2014